Assessing the frequency, phenotype and function of plasmacytoid dendritic cells and T cells in blood and skin of patients with skin fibrosing disorders

Assessing the frequency, phenotype and function of plasmacytoid dendritic cells and T cells in blood and skin of patients with skin fibrosing disorders - Analysis of immune cells in skin fibrosing disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47886

Enrollment

150

Registered

2013-10-14

Start date

2014-12-16

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic sclerosis - scleroderma / Localized scleroderma - morphea / Eosinophilic fasciitis - ?

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Age range: 18 - 75 years -Diagnosed with systemic sclerosis, localized scleroderma, eosinophilic fasciitis or psoriasis.

Exclusion criteria

Exclusion criteria: --Current use of coumarin derivatives -Current use of cyclophosphamide -IV corticosteroids in the last 14 days for inclusion -Age

Design outcomes

Primary

Measure	Time frame
Number, phenotype and function of plasmacytoid dendritic cells and T cells in the skin and blood of patients suffering from SSc, LS or EF and in healthy controls / patients with psoriasis.	—

Countries

Netherlands

Outcome results